Inclusion body myositis presenting as treatment-resistant polymyositis

Clinical heterogeneity and treatment res

Clinical heterogeneity and treatment response in inclusion body myositis

✍ Miriam Richter Cohen; A. R. Sulaiman; John C. Garancis; Robert L. Wortmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Measures of adult and juvenile dermatomy

Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)

✍ Lisa G. Rider; Victoria P. Werth; Adam M. Huber; Helene Alexanderson; Anand Prah 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 293 KB 👁 3 views